DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Biotech Company Officially Launches Cloud Lab Service Powered by Autonomous Lab Infrastructure
PR Newswire (March 2, 2026) reported that Ginkgo Bioworks (NYSE: DNA) officially launched Ginkgo Cloud Lab, a new interface that allows researchers to transition their benchwork to Ginkgo's autonomous lab infrastructure directly through a web browser. The Cloud Lab runs on Ginkgo's proprietary Reconfigurable Automation Carts (RACs)—modular units combining high-precision robotic arms, maglev sample transport tracks, and industrial-grade software to create a flexible laboratory environment. It provides remote access to a fleet of over 70 instruments spanning critical biological unit operations including sample preparation, liquid handling, analytical readouts, storage, and incubation. The core of the initial launch is an AI-driven agent called EstiMate, which for the first time allows scientists to submit a protocol in human language and receive an immediate assessment of compatibility with Ginkgo's current autonomous fleet, along with transparent pricing for running the protocol. CEO Jason Kelly stated that autonomous labs are ready to scale and accelerate high-mix benchwork, and that opening up the autonomous infrastructure through the Cloud Lab gives scientists access to these tools today. Ginkgo Cloud Lab is part of the company's 2026 strategic shift to move all R&D services onto Nebula, its autonomous lab in Boston, MA, and decommission traditional lab benches in favor of predictable and programmable robotic infrastructure. Ginkgo is inviting researchers from academia to global biopharmaceutical companies to submit their specific protocols for development on the Cloud Lab; feasibility reports and price quotes can be requested at cloud.ginkgo.bio.
Wearable Patch Enables Pain-Free At-Home Hormone Monitoring for IVF
The Australia Today (March 24, 2026) reported that Melbourne startup Symex Labs, building on research by Prof. Sharath Sriram—the fourth Chief Scientist of Western Australia and Professor at RMIT University—is developing a wearable hormone monitoring patch for IVF (in vitro fertilization) patients. The patch uses microscopic microneedles to access hormones (progesterone and oestradiol) in the patient's interstitial fluid beneath the skin, producing an electrical signal to inform IVF clinicians when a patient is ready for embryo transfer. The device aims to eliminate the need for multiple blood draws at clinics, enabling women undergoing IVF to monitor hormone levels from home—particularly benefiting those in regional areas who currently travel long distances for tests. Funding of A$2.5 million has been secured from the Federal Government, the University of Melbourne's Genesis Pre-Seed Fund, Monash IVF, RMIT, and Breakthrough Victoria's A$100 million University Innovation Platform initiative. Monash IVF Research Director Mark Green noted the device could save patients time, money, and stress. Beyond IVF, the technology has potential applications in monitoring polycystic ovary syndrome (PCOS), perimenopause, and menopause, and could integrate with consumer health apps for personalized, real-time hormone tracking. The first in-human pilot study is expected within 18 months, with commercialization slated for early 2028.
MIT Develops 'PlasmoSniff' Chip-Scale Sensor Diagnosing Pneumonia via Breath in Under 10 Minutes Inhaled Nanoparticles Release Biomarkers Cleaved by Disease Enzymes Detected at Ultra-Low Concentrations by Portable Device
Mirage News (March 16, 2026) covered MIT engineers' development of 'PlasmoSniff,' a breath-based test for diagnosing pneumonia. Conventional pneumonia diagnosis requires chest X-rays or hours of lab testing, but PlasmoSniff uses inhalable nanoparticles (similar to inhaling asthma medicine). In healthy individuals, nanoparticles circulate through the body and are expelled intact. If a disease like pneumonia is present, enzymes produced by the infection cleave and release synthetic biomarkers from the nanoparticles; these biomarkers are then exhaled and detected. PlasmoSniff uses a portable, chip-scale sensor to detect these exhaled biomarkers at extremely low concentrations—without laboratory-grade instruments. The team envisions patients inhaling nanoparticles and receiving a diagnosis within approximately 10 minutes in clinical or at-home settings. Until now, detecting exhaled biomarkers required large lab instruments unavailable in most doctors' offices. Future plans include integrating the sensor into a handheld instrument and expanding applications to other lung diseases beyond pneumonia. Breath diagnostics are attracting attention as a non-invasive, low-cost, rapid direction in infectious disease diagnosis.
New 'liver-on-a-chip' device could make drug safety testing more reliable
Research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences and collaborating institutions suggests that the PhysioMimix LC12 device holds promise for more reliable drug safety testing compared to traditional methods. This "liver-on-a-chip" technology, developed by UK-based CN Bio, aims to improve human-relevant predictions and reduce reliance on animal testing. A recent study evaluated the PhysioMimix LC12's ability to replicate species-specific drug toxicities using cells from various animals and humans. The findings indicate that the LC12 offers a more predictive and physiologically relevant approach for assessing drug-induced liver injury, supporting long-term liver cell culture and enabling longitudinal assessments. Despite some limitations in large-scale screening and cost, this technology represents a significant step towards safer, more predictive drug testing by integrating with advanced molecular analysis tools to provide a clearer understanding of drug-induced liver damage.
Tiny Bubbles Help Cancer Invade New Organs – And May Be Key to Stopping It
Scientists are studying how cancer metastasizes to other organs via invisible "extracellular vesicles" – tiny bubbles released from cells that carry genetic information and can transform healthy cells into cancerous ones. The research team is developing artificial lipid nanoparticles (liposomes) that can deliver drugs directly to cancer cells, aiming to prevent metastasis, enhance treatment effectiveness, and reduce side effects. They are observing the absorption of liposomes by liver cancer cells to understand how their composition influences cellular uptake. The long-term goal is to utilize these liposomes as drug delivery systems for anti-cancer agents like turmeric and paclitaxel, efficiently delivering them to target cells to block cancer metastasis and improve patient survival rates, paving the way for new, more targeted treatments.
Light-activated catalyst developed for PFAS degradation
An international team led by the University of Bath has developed a photothermal catalyst that uses sunlight to break down PFAS ('forever chemicals') into carbon dioxide and fluoride. The carbon-based catalyst, combined with a rigid microporous polymer, enables efficient PFAS binding and degradation under neutral pH conditions typical of natural environments, with additional potential as a fluoride-detection sensor for environmental monitoring.
Not just shock absorption—foam that supports movement. Design philosophy for a new material achieving both conflicting properties.
Walking, running, standing for extended periods—reducing the impact on the feet during these everyday activities has long been a challenge. While conventional cushioning materials excel at shock absorption, they often lack the rebound force needed to support movement, making it difficult to achieve both softness and propulsion. To address this challenge, Achilles developed “ACROFOAM,” a polyurethane foam material designed as a functional material aiming to balance shock absorption and rebound properties. The origins of its development date back to 2014. At that time, one reason beginners quit marathon running within about a year was the strain on their lower back and knees. A material needed that would soften impact while maintaining ease of running, prompting the start of development. The first material born was its predecessor, “MEDIFOAM”. When bearing weight, it softly absorbed impact while returning energy, achieving a sensation that prevented excessive sinking and supported the push-off. ACROFOAM is the material that evolved this technology and expanded its applications. Its key feature lies in proprietary technology controlling the bubble structure within the polyurethane foam. By optimizing bubble size and structure, it achieves both “rebound elasticity” and “shock absorption” – properties that often conflict. It can be designed across a wide range of hardness levels, covering everything from an extremely soft feel to high rigidity. Furthermore, it exhibits durability with minimal permanent deformation and performance degradation even after repeated compression. It supports three-dimensional molding, enabling designs tailored to applications like footwear insoles and mats. Mr. Omura, who led the development, stated regarding future plans: “We aim to expand beyond traditional footwear applications into new fields such as industrial components and daily necessities.” As a material balancing comfort and ease of movement, its application range is expected to grow.
BioGAP-Ultra: A Modular Edge-AI Platform for Wearable Multimodal Biosignal Acquisition and Processing
This work introduces BioGAP-Ultra, an advanced, low-power, and flexible wearable multimodal biosensing platform. It enables synchronized acquisition of various electrophysiological and hemodynamic signals (EEG, EMG, ECG, PPG) and supports embedded AI processing with state-of-the-art energy efficiency. BioGAP-Ultra expands on previous designs with increased storage, improved wireless connectivity (up to 1.4 Mbit/s), and more signal modalities (from 3 to 5). It comes with real-time visualization software for mobile phones and demonstrates versatility through integration into different wearable form factors, showcasing edge-AI capabilities like PAT estimation and reach-and-grasp motion classification. Hardware and software design files are open-source.
AI Glasses: Ushering in the Next Generation of Advanced Wearable Technology
AI glasses are rapidly advancing, offering features like teleprompting, object recognition, and real-time translation, but face significant battery life challenges due to high-performance processors and increased leakage current. NXP Semiconductors addresses this with its i.MX RT low-power product family, specifically the i.MX RT700. This chip supports a dual-architecture approach, enabling extended battery life through an application processor and coprocessor, or a lighter, smaller MCU-only design. The RT700 optimizes power consumption in various scenarios, including voice control with sensor mode operation under 2mW, and high-performance display modes, leveraging technologies like MIPI ULPS for efficient multimedia processing.
Development of an ultrasonic sensor capable of cuffless, non-invasive blood pressure measurement
A research team led by Dr. Shin Hur at KIMM, in collaboration with KIST, has developed the world's first skin-attachable, non-invasive blood pressure sensor using PMN-PT single-crystal piezoelectric composites and a low-temperature soldering process. This cuffless ultrasonic sensor accurately tracks real-time vascular diameter changes to measure blood pressure within ±4 mmHg, meeting AAMI clinical standards. It is poised to become a core technology for future wearable healthcare devices and smart medical monitoring platforms.
Munich startup Twogee Biotech raises €2.16M to turn residual biomass into sustainable building blocks
Munich-based startup Twogee Biotech, founded in 2024, has secured €2.16 million in seed funding to bring its enzyme platform to market and help the chemical industry transition to circular, low-CO2 production. The company's technology enables the conversion of underutilized biomass side streams, such as agricultural residues, into usable raw materials with significantly reduced CO2 footprints. This creates new circular value chains, lessens reliance on food crops, and supports regional production models. Twogee aims to reduce transport-associated emissions and help partners operate more flexibly and economically through a licensing model with local enzyme production at customer sites.
“Agriculture” × ‘Decarbonization’ with the Power of Pine Resin. Arakawa Chemical Industries Launches New Material “EcoRosin(R)” on January 7th, Achieving Both Yield Improvement and CO₂ Reduction
Arakawa Chemical Industries, Ltd. (Headquarters: Chuo-ku, Osaka; President and CEO: Nobuyuki Takagi) will begin selling its biostimulant material “EcoRosin®,” which mitigates environmental stress caused by abnormal weather and other factors, on the following e-commerce sites starting January 7, 2026. This product leverages the company's approximately 150 years of research into pine resin.
Sharemedical Announces "Nexstetho HUB" to Integrate Interview and Auscultation for Seamless Online Medical Examinations, Optimal for Medical MaaS and Inter-Facility Online Consultations
Sharemedical Inc. has announced "Nexstetho HUB," a new product that integrates with its digital stethoscope "Nexstetho." This device resolves the issue of switching between patient interviews and auscultation during online medical examinations, enabling seamless remote auscultation. It is particularly suited for Medical MaaS vehicles and inter-facility online consultations, aiming to provide high-quality remote medical care, improve diagnostic accuracy for doctors, and reduce the burden on on-site staff. Nexstetho HUB will be unveiled at the 53rd Japanese Association for Acute Medicine General Assembly on October 28, 2025.